Based on these findings, LY3298176, the dual GIP and GLP-1 receptor agonist, demonstrated superior efficacy in glucose control and weight loss compared to dulaglutide
If a lower dose is working well for you, sticking with it is fine
En la DM2 tambin se encuentra alterado el efecto incretina como un evento secundario a otros defectos metablicos y no como un evento primario de la fisiopatologa de esta enfermedad 42 , demostrndose una resistencia a la accin de estas hormonas, en especial a la ltima fase de respuesta del GLP-1 43-45
Our dedicated team is ready to help you reach your health goals with tailored, compassionate care that prioritizes your well-being
When a medication is metabolized, your body is chemically altering the medication so that it can be eliminated from your body more easily
Just as patients with high blood pressure require medication, individuals experiencing weight regain after VSG may need medical interventions beyond lifestyle modifications